Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of ertapenem sodium (Invanz) in
treatment of complicated urinary tract infections with respect to the proportion of patients
with a favorable microbiological response at 5-9 days post therapy.